Adas, Hamida .
HRN: 21-94-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/07/2025
05/13/2025
IVTT
290mg
Q6h
Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes